![]() Actinium Pharmaceuticals Actinium Pharmaceuticals is a biopharmaceutical company developing targeted payload immunotherapeutics for the treatment of advanced cancers. | ![]() Quark Pharmaceuticals Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics. | ![]() Horizon Discovery Horizon Discovery Group is a company that supplies genetically defined cell lines, in vivo models, reference standards, and contract research services to academia and biopharma. | ![]() Lionex Lionex is a company that produces and supplies mycobacterial antigens and monoclonal antibodies for research. | ![]() LabConnect LabConnect is a provider of central laboratory support services for analytically and logistically complex studies such as immuno-oncology, cell and gene therapies, and rare and orphan diseases. | |
Founding Date | Founding Date 2000 | Founding Date 1994 | Founding Date 2005 | Founding Date N/A | Founding Date 2002 |
Type | Type Public | Type Private | Type Subsidiary | Type Private | Type Private |
Tags | |||||
Locations | Locations New York, US HQ | Locations Newark, US HQ | Locations Waterbeach, GB HQ Boyertown, US Lafayette, US St. Louis, US | Locations Braunschweig, DE HQ | Locations Johnson City, US HQ Buenos Aires, AR Sydney, AU Minsk, BY Tbilisi, GE Mumbai, IN Tel Aviv Yafo, IL see more |
Employees | Employees 2517% decrease | Employees 781% decrease | Employees 114 | Employees N/A | Employees 1961% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) $90k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) £62.9m (FY, 2019) | Revenue (est.) N/A | Revenue (est.) N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 10m (almost 16 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 24.5m (almost 9 years ago) |
Total funding raised | Total funding raised $ 7m | Total funding raised $ 37m | Total funding raised $ 50.2m | Total funding raised N/A | Total funding raised $ 28.5m |

Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics.
View company
Horizon Discovery Group is a company that supplies genetically defined cell lines, in vivo models, reference standards, and contract research services to academia and biopharma.
View company
Lionex is a company that produces and supplies mycobacterial antigens and monoclonal antibodies for research.
View company
LabConnect is a provider of central laboratory support services for analytically and logistically complex studies such as immuno-oncology, cell and gene therapies, and rare and orphan diseases.
View company